These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 29719090)

  • 1. Apolipoprotein C1 promotes prostate cancer cell proliferation in vitro.
    Su WP; Sun LN; Yang SL; Zhao H; Zeng TY; Wu WZ; Wang D
    J Biochem Mol Toxicol; 2018 May; 32(7):e22158. PubMed ID: 29719090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. APOC1 promotes the progression of osteosarcoma by binding to MTCH2.
    Li R; He H; He X
    Exp Ther Med; 2023 Apr; 25(4):163. PubMed ID: 36911382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apolipoprotein C1 (APOC1) promotes tumor progression via MAPK signaling pathways in colorectal cancer.
    Ren H; Chen Z; Yang L; Xiong W; Yang H; Xu K; Zhai E; Ding L; He Y; Song X
    Cancer Manag Res; 2019; 11():4917-4930. PubMed ID: 31213910
    [No Abstract]   [Full Text] [Related]  

  • 4. Apolipoprotein C1 (APOC1): A Novel Diagnostic and Prognostic Biomarker for Cervical Cancer.
    Shi X; Wang J; Dai S; Qin L; Zhou J; Chen Y
    Onco Targets Ther; 2020; 13():12881-12891. PubMed ID: 33364782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TROAP regulates prostate cancer progression via the WNT3/survivin signalling pathways.
    Ye J; Chu C; Chen M; Shi Z; Gan S; Qu F; Pan X; Yang Q; Tian Y; Wang L; Yang W; Cui X
    Oncol Rep; 2019 Feb; 41(2):1169-1179. PubMed ID: 30431120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Apolipoprotein C1 is involved in breast cancer progression via EMT and MAPK/JNK pathway.
    Zhang H; Wang Y; Liu C; Li W; Zhou F; Wang X; Zheng J
    Pathol Res Pract; 2022 Jan; 229():153746. PubMed ID: 34952429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apolipoprotein C1 promotes tumor progression in gastric cancer.
    Gu Q; Zhan T; Guan X; Lai C; Lu NA; Wang G; Xu L; Gao X; Zhang J
    Oncol Res; 2023; 31(3):287-297. PubMed ID: 37305389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Knockdown of PYCR1 inhibits cell proliferation and colony formation via cell cycle arrest and apoptosis in prostate cancer.
    Zeng T; Zhu L; Liao M; Zhuo W; Yang S; Wu W; Wang D
    Med Oncol; 2017 Feb; 34(2):27. PubMed ID: 28078560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coatomer subunit beta 2 (COPB2), identified by label-free quantitative proteomics, regulates cell proliferation and apoptosis in human prostate carcinoma cells.
    Mi Y; Sun C; Wei B; Sun F; Guo Y; Hu Q; Ding W; Zhu L; Xia G
    Biochem Biophys Res Commun; 2018 Jan; 495(1):473-480. PubMed ID: 29129687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ApoC1 promotes glioma metastasis by enhancing epithelial-mesenchymal transition and activating the STAT3 pathway.
    Liang R; Zhang G; Xu W; Liu W; Tang Y
    Neurol Res; 2023 Mar; 45(3):268-275. PubMed ID: 36302088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Downregulation of the nucleosome-binding protein 1 (NSBP1) gene can inhibit the in vitro and in vivo proliferation of prostate cancer cells.
    Jiang N; Zhou LQ; Zhang XY
    Asian J Androl; 2010 Sep; 12(5):709-17. PubMed ID: 20531280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of apolipoprotein C1 in clear cell renal cell carcinoma: An oncogenic gene and a prognostic marker.
    Wang HJ; Ma YX; Wang AH; Jiang YS; Jiang XZ
    Kaohsiung J Med Sci; 2021 May; 37(5):419-426. PubMed ID: 33305507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apolipoprotein C1 stimulates the malignant process of renal cell carcinoma via the Wnt3a signaling.
    Jiang H; Tang JY; Xue D; Chen YM; Wu TC; Zhuang QF; He XZ
    Cancer Cell Int; 2021 Jan; 21(1):41. PubMed ID: 33430855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apolipoprotein C1 (APOC1) as a novel diagnostic and prognostic biomarker for gastric cancer.
    Yi J; Ren L; Wu J; Li W; Zheng X; Du G; Wang J
    Ann Transl Med; 2019 Aug; 7(16):380. PubMed ID: 31555694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aloperine executes antitumor effects through the induction of apoptosis and cell cycle arrest in prostate cancer in vitro and in vivo.
    Ling Z; Guan H; You Z; Wang C; Hu L; Zhang L; Wang Y; Chen S; Xu B; Chen M
    Onco Targets Ther; 2018; 11():2735-2743. PubMed ID: 29785122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apolipoprotein C1 (APOC1): A Novel Diagnostic and Prognostic Biomarker for Clear Cell Renal Cell Carcinoma.
    Cui Y; Miao C; Hou C; Wang Z; Liu B
    Front Oncol; 2020; 10():1436. PubMed ID: 32974161
    [No Abstract]   [Full Text] [Related]  

  • 17. High expression of lncRNA SNHG1 in prostate cancer patients and inhibition of SNHG1 suppresses cell proliferation and promotes apoptosis.
    Tang Q; Li Z; Han W; Cheng S; Wang Y
    Indian J Pathol Microbiol; 2020; 63(4):575-580. PubMed ID: 33154308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of apolipoprotein C1 in hepatitis C virus infection and morphogenesis.
    Zhang H; Qiao L; Luo G
    Virology; 2018 Nov; 524():1-9. PubMed ID: 30130702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of Apolipoprotein C1 (APOC1) in Clear Cell Renal Cell Carcinoma and Its Prognostic Significance.
    Xiao H; Xu Y
    Med Sci Monit; 2021 Feb; 27():e929347. PubMed ID: 33591959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Knockdown of REGγ inhibits proliferation by inducing apoptosis and cell cycle arrest in prostate cancer.
    Chen S; Wang L; Xu C; Chen H; Peng B; Xu Y; Yao X; Li L; Zheng J
    Am J Transl Res; 2017; 9(8):3787-3795. PubMed ID: 28861169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.